newsfilter
← Latest News
ClinicalTrials.gov·

Extension Study of ABP-20001 to Evaluate Safety and Efficacy of Repeat Treatments of ABP-450 for Migraine Prevention - NCT05016661

Incidence of Treatment Emergent Adverse Events, Change in Monthly Migraine Days, Percentage of Patients with Reduction in Mean Migraine Days (MMD), (and 5 more...)